Tumor necrosis factor-alpha is persistently expressed in cardiac allografts in the absence of histological or clinical evidence of rejection.
Torre-Amione
G
G
Multi-Organ Transplant Center, Methodist Hospital, Houston, Texas, USA.
MacLellan
W
W
Kapadia
S
S
Weilbaecher
D
D
Farmer
J
J
Young
J
J
Mann
D
D
D001706:Biopsy; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology; D006085:Graft Survival / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D015166:Monitoring, Immunologic; D009206:Myocardium / Q000276:immunology*; D013997:Time Factors; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*
D014409:Tumor Necrosis Factor-alpha